A daily briefing highlights key news including Bengal's voter roll crisis, concerns surrounding the HPV vaccine, and the death of a student in Kerala.

The HPV vaccine, which prevents cervical cancer in women, is also effective against multiple cancers in men but remains tragically underused.

The Delhi High Court has raised serious concerns regarding safety issues in the ongoing Human Papillomavirus (HPV) vaccine rollout drive. The court described the matter as a 'very serious issue' requiring attention.

This article debunks five false claims and manipulations made by MEP Ewa Zajączkowska-Hernik regarding the HPV vaccine, including assertions that it is a medical experiment causing infertility and is banned in many countries.

A court case involves divorced parents with differing views on child vaccination, specifically the HPV vaccine, as the father seeks to vaccinate his 15-year-old daughter against the mother's wishes.

A British study highlights the significant impact of HPV vaccination, leading cancer experts to believe that a future free from cervical cancer is now a realistic prospect.

The HPV vaccine developed by the Serum Institute of India is slated for inclusion in the country's national immunisation program, though its implementation is expected after 2027.

Serbia, facing high rates of cervical cancer, has expanded its HPV immunization program. The article addresses common misconceptions about the HPV vaccine, emphasizing its role in preventing the disease.

The Portuguese League Against Cancer considers the expansion of the HPV vaccine to individuals up to 26 years old a "significant advance" in cancer prevention and advocates for further expansion to other age groups and vulnerable populations.

North Macedonia reports that its HPV vaccine coverage for two doses stands at 51.5%, significantly below the recommended average. The inclusion of boys in the vaccination program has contributed to an increase in the number of vaccinated children and overall coverage.

Public discussion is focusing on common doubts and questions surrounding the HPV vaccine, particularly concerning its availability and use for adults.

With the government having launched the HPV vaccination drive across the country, here are answers to some frequently asked questions about the virus and the vaccine

An ongoing study led by ICMR, which is testing whether a single dose of the India-made Cervavac vaccine generates enough protective antibodies and generates a stable immune response compared to a…

After his wife's expensive cervical cancer treatment, a father is advocating for the HPV vaccine to protect his daughters, highlighting the financial and health impact of the disease.

The special campaign will run in mission mode over a three-month period, during which eligible girls can receive the vaccine daily at designated facilities

India is set to launch a nationwide HPV vaccination campaign on February 28, offering free vaccination facilities at all government health centers.

A Swedish study has investigated the long-term effectiveness of the HPV vaccine, showing protection against cervical cancer for up to 18 years after immunization. The research analyzed data from over 900,000 women.

Schools in Delhi are actively working to build parents' trust and encourage HPV vaccination among students, describing the injection as a 'tiny pinprick'.

A cervical cancer survivor is advocating for increased HPV vaccine uptake, emphasizing that a single injection could have significantly altered her life. She highlights the critical importance of prevention against the disease.

The success of the HPV vaccine raises questions about whether cervical screening protocols can be reduced.

A new study from Queen Mary University of London, published in The Lancet, reports that the HPV vaccine has eliminated cervical cancer deaths in women aged 20-24 in England between 2020 and 2024.

Al Jazeera explores how the HPV vaccine is fundamentally changing the way we approach and think about cancer, particularly in terms of prevention.

The HPV vaccine has demonstrated significant success in the United Kingdom, effectively reducing the risk of cervical cancer death before age 30 to nearly zero.

Reports indicate a rise in the number of girls and boys receiving the HPV vaccine.

There is increasing recognition and awareness regarding the benefits of the Human Papillomavirus (HPV) vaccine for men.

The HPV vaccine, previously associated primarily with adolescence, is now recognized to offer a new window of opportunity for cancer prevention for individuals up to 26 years old.

An expert explains why men should receive the HPV vaccine, which was previously recommended primarily for women to protect against cervical cancer, highlighting its clear benefits for males.

Despite a statewide push, misinformation is reportedly slowing the uptake of the HPV vaccine.

Serbia faces World Day Against Human Papillomavirus/HPV with still insufficient vaccination coverage of children, despite it being an infection that...

HPV vaccine will be administered to 3.45 lakh girls aged between 14 and 15 in the next three months, says the Chief Minister

Croatia is set to make the HPV vaccine mandatory next year for children aged 14-15, with free vaccination currently available and additional options for young people up to 25 years old.

A new Swedish study has found that the HPV vaccine provides long-lasting protection against cervical cancer for at least 18 years, significantly reducing the risk.

A 'Coffee Break' segment highlights a promising breakthrough in HIV therapy and also touches upon the HPV vaccine, alongside other topics like data centers and ecological collapse.

The Khyber Pakhtunkhwa province is set to launch a campaign in November targeting 2.9 million girls with the HPV vaccine to prevent cervical cancer.

A new study conducted in England has revealed that widespread HPV vaccination, particularly among 12-13 year old girls, has led to a significant reduction in cervical cancer mortality, demonstrating a nearly zero risk.

New landmark research in Britain indicates that children vaccinated against HPV at ages 12-13 have an almost zero risk of dying from cervical cancer. The study highlights the vaccine's effectiveness in preventing the disease.

Experts are addressing common misconceptions surrounding the HPV vaccine, including concerns about sterility and safety. The aim is to provide accurate information and encourage vaccination.

The HPV vaccine is now available free of charge in Serbia for individuals up to 45 years of age. Experts have shared their opinions on this expanded state-funded program.

An article highlights the importance of vaccinating boys against HPV as a crucial strategy to achieve the goal of ending cervical cancer.

The HPV vaccine is being offered free of charge to children aged 9-14 in Polish schools, with the Health Minister emphasizing its effectiveness and encouraging wider uptake.

The most common misconception about HPV is that if you do not have a cervix, you are safe. Scientifically, this is far from the truth.

The move aims to protect 9.84 lakh g in the 9-14 age group from cervical cancer

The HPV vaccine exists, but the virus still circulates. Between these two facts lies society's decision.

A fact-check report clarifies that claims circulating about the HPV vaccine endangering children are false, reassuring the public about its safety.

India's Prime Minister is set to launch a nationwide HPV vaccine campaign from Rajasthan on February 28, with parental consent being a mandatory requirement for vaccination.

The Ghana Health Service (GHS) has officially incorporated the Human Papillomavirus (HPV) vaccine into the nation's routine immunisation programme.